An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

Link to article at PubMed

Science. 2021 Nov 2:eabl4784. doi: 10.1126/science.abl4784. Online ahead of print.

ABSTRACT

[Figure: see text].

PMID:34726479 | DOI:10.1126/science.abl4784

Leave a Reply

Your email address will not be published. Required fields are marked *